Surface Oncology, Inc. (11) | License Agreements (2)
- Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Filed With SEC on May 5, 2021)
- License Agreement, dated as of December 16, 2020, by and between the Company and GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 4) LIMITED (Filed With SEC on December 17, 2020)
